转录凝结物:在血液恶性瘤中表观遗传重编程和治疗点
Kevin Qiu1, Qing Yin1, Chongzhi Zang2
1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.
Cancers
|October 16, 2025
概括
癌细胞依赖于超级增强剂进行瘤转录. 转录凝聚物 (TCs) 调节这个过程,为各种瘤提供新的治疗点,包括血液性恶性瘤.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 生物化学 生物化学
背景情况:
- 转录对于癌症至关重要,涉及特定核部位的蛋白质复合体.
- 转录因子将DNA基因绑定到增强剂和超级增强剂上,以调节基因表达.
- 超级增强剂驱动瘤转录,在癌细胞中产生依赖性.
研究的目的:
- 探索转录凝聚物 (TCs) 在癌症中的作用.
- 突出TC作为癌症治疗的潜在治疗点.
主要方法:
- 该研究的重点是转录凝聚物 (TCs) 的概念及其通过液-液相分离 (LLPS) 的形成.
- 它回顾了TCs在癌细胞内调节瘤转录和基因表达中的作用.
主要成果:
- 转录凝聚物 (TCs) 是核,没有膜的组件,调节瘤基因表达.
- 这些凝结物促进了瘤转录的时空控制,推动了癌症的诱导和维持.
- 癌细胞表现出对超强增强器驱动的转录成,由TCs调解.
结论:
- 针对TC是一种有前途的治疗策略,用于各种瘤.
- 旨在TC组装和激活的抑制剂和策略可能对血液恶性瘤和其他癌症有效.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
Lineage Commitment
4.1K
Commitment is the process whereby stem cells:
4.1K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K


